Xuan Xu
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 6
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 3
- Molecular Biology top 10%
- Gut microbiota and health 7
- Peroxisome Proliferator-Activated Receptors 5
- RNA modifications and cancer 4
- Circular RNAs in diseases 4
- Journals
- International Journal of Biological Sciences (3 papers)Scientific Reports (2 papers)Gut Microbes (2 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Xuan Xu
60 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 165
- Applied Microbiology and Biotechnology 61
- Cancer Research 290
- Endocrinology 90
- Molecular Biology 773
Countries citing papers authored by Xuan Xu
This map shows the geographic impact of Xuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Xu more than expected).
Fields of papers citing papers by Xuan Xu
This network shows the impact of papers produced by Xuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Xu. The network helps show where Xuan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 52 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 37 | |
| 13 | 2020 | 17 | |
| 14 | 2018 | 22 | |
| 15 | 2018 | 56 | |
| 16 | 2017 | 21 | |
| 17 | 2017 | 7 | |
| 18 | 2017 | 108 | |
| 19 | 2015 | 35 | |
| 20 | 2006 | 16 |
About Xuan Xu
Xuan Xu is a scholar working on Molecular Medicine, Cancer Research and Endocrinology, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Gut microbiota and health (7 papers), Antibiotic Resistance in Bacteria (6 papers), Cancer-related molecular mechanisms research (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (4 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Molecular Medicine (165 citations), Applied Microbiology and Biotechnology (61 citations) and Cancer Research (290 citations). Xuan Xu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Thomas G. Boyer, Andreas Hecht, Seokjoong Kim, Haiying Zhou, Yidong Yang, Yiming Lei, Liu Pin, Mei Luo, Jingfu Qiu and Huiling Liu. Their work appears in journals such as International Journal of Biological Sciences, Scientific Reports, Gut Microbes, Microbial Pathogenesis and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.